intravitreal injection full details type,kaam kya krta hai all things
Reading File
Finding Sources
Finding Sources
Searching the Web
intravitreal injection types drugs mechanism procedure ophthalmology complete guide
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive information from multiple authoritative sources. Let me compile the full answer.
Intravitreal Injection - Complete Guide (Hindi-English Mix)
Kya Hai? (Definition)
Intravitreal injection ek aisi procedure hai jisme dawai seedha vitreous cavity (aankhon ke andar ka gel-filled space) mein inject ki jaati hai. Yeh route isliye use hota hai kyunki:
- Blood-retinal barrier systemic drugs ko retina tak aasaani se pahunchne nahi deta
- Directly targeted tissue (retina/macula) tak maximum concentration milti hai
- Systemic side effects minimally hote hain kyunki dose bahut choti hoti hai
Sabse pehle 1911 mein Ohm ne air bubble ke liye use kiya tha (retinal detachment tamponade ke liye). Modern drug therapy 1940s mein penicillin se shuru hui.
Anatomy - Injection Kahan Lagti Hai?
Injection pars plana route se lagti hai:
- 3.5-4 mm posterior to the limbus (phakic eye mein)
- 3.0-3.5 mm posterior to the limbus (pseudophakic/aphakic eye mein)
- Infero-temporal quadrant preferred hai
- 30-gauge needle, 5/8 inch syringe use hoti hai
- Volume: typically 0.05-0.1 mL
Types of Intravitreal Injections - Kaam Kya Karta Hai
1. Anti-VEGF Agents (Sabse Common)
VEGF (Vascular Endothelial Growth Factor) ek protein hai jo abnormal blood vessel growth aur fluid leakage cause karta hai. Anti-VEGF drugs yeh block karte hain.
| Drug | Dose | Mechanism | Status |
|---|---|---|---|
| Bevacizumab (Avastin) | 1.25 mg/0.05 mL | Full-length anti-VEGF antibody | Off-label, compounding pharmacy |
| Ranibizumab (Lucentis) | 0.3 mg/0.05 mL | Bevacizumab ka variant (Fab fragment) | FDA-approved |
| Aflibercept (Eylea) | 2 mg/0.05 mL | Decoy receptor for VEGF-A | FDA-approved |
| Brolucizumab (Beovu) | 6 mg/0.05 mL | Single-chain antibody fragment | FDA-approved, longer duration |
| Pegaptanib (Macugen) | 0.3 mg/0.09 mL | VEGF-165 isoform ko bind karta hai | FDA-approved (older) |
Kaam kya karta hai:
- Choroidal neovascularization (CNV) ko rokta hai
- Macular edema reduce karta hai
- Fluid leakage band karta hai
- Vision improve/stabilize karta hai
DRCR.net Protocol T ke according: 5-year outcomes mein aflibercept, bevacizumab aur ranibizumab mein koi significant difference nahi tha - Kanski's Clinical Ophthalmology 10th ed.
2. Intravitreal Steroids
| Drug | Form | Dose | Duration |
|---|---|---|---|
| Triamcinolone acetonide | Suspension | 1-4 mg/0.1 mL | 2-4 months (IOP raise) |
| Dexamethasone implant (Ozurdex) | Biodegradable 0.7 mg implant | 0.7 mg | Up to 6 months |
| Fluocinolone acetonide (Iluvien) | Implant | 0.19/0.59 mg | Long-term (years) |
Kaam kya karta hai:
- Inflammation reduce karta hai
- Macular edema mein kaam aata hai jab anti-VEGF fail ho
- Uveitis mein use hota hai
- DME (Diabetic Macular Edema) mein second-line therapy
Important: IOP badhna (steroid-induced glaucoma) ek major side effect hai - typically 2-4 weeks baad shuru hota hai - Kanski's, p. 530.
3. Intravitreal Antibiotics (Endophthalmitis Treatment)
Yeh emergency setting mein use hote hain jab eye infection (endophthalmitis) ho.
| Drug | Dose | Coverage |
|---|---|---|
| Vancomycin | 1-2 mg/0.1 mL | Gram-positive (including MRSA) |
| Ceftazidime | 2 mg/0.1 mL | Gram-negative (including Pseudomonas) |
| Amikacin | 0.4 mg/0.1 mL | Alternative to ceftazidime (penicillin allergy) - more retinal toxic |
| Cefazolin | 2.25 mg/0.1 mL | Gram-positive |
Yeh MIC (Minimum Inhibitory Concentration) se upar levels achieve karte hain vitreous mein, jo systemic route se possible nahi tha - Kanski's, p. 345.
4. Intravitreal Antivirals/Antifungals
| Drug | Use |
|---|---|
| Fomivirsen | CMV retinitis (antisense oligonucleotide) |
| Foscarnet | CMV retinitis (IV ya intravitreal) |
| Cidofovir | CMV retinitis |
| Ganciclovir | CMV/viral retinitis |
5. Intravitreal Gas (Special Use)
- SF6, C3F8, Air - Retinal detachment mein tamponade ke liye
- rTPA (tissue plasminogen activator) - Subretinal hemorrhage ko dissolve karne ke liye
Indications (Kiski Bimari Mein Use Hota Hai?)
| Condition | First-line Drug |
|---|---|
| Neovascular AMD (Wet) | Anti-VEGF (aflibercept/ranibizumab/bevacizumab) |
| Diabetic Macular Edema (DME) | Anti-VEGF first-line; steroid second-line |
| Retinal Vein Occlusion (CRVO/BRVO) + ME | Anti-VEGF; Dexamethasone implant |
| Endophthalmitis | Vancomycin + Ceftazidime |
| CMV Retinitis | Fomivirsen/Foscarnet/Cidofovir |
| Uveitic Macular Edema | Dexamethasone/Fluocinolone implant |
| Choroidal Neovascularization | Anti-VEGF |
| Retinal Detachment | Gas bubble |
Procedure Step-by-Step
- Patient ko reclined chair ya bed pe bithao
- Topical anesthetic drops - eye numb karo (tetracaine/proparacaine)
- Povidone-iodine (5-10%) - eyelid margins pe apply karo (bacteria kill karne ke liye)
- Eyelid speculum - eyelid ko open rakho
- 5% Povidone-iodine - conjunctival surface pe apply karo (injection site pe) - kam se kam 30 seconds pahle
- Patient ko specific direction mein dekhne kaho
- Pars plana se needle insert - 3.5-4 mm posterior to limbus
- Slowly inject - 0.05-0.1 mL
- Needle withdraw karo - cotton-tipped applicator se site dabao
- IOP check karo - post-injection IOP raised ho sakta hai
- Central retinal artery pulsations - indirect ophthalmoscopy se check karo
Masks recommended hain - endophthalmitis risk respiratory droplets se bhi ho sakta hai - Retina Specialist Journal.
Complications
| Complication | Frequency | Notes |
|---|---|---|
| Endophthalmitis | Rare (~0.05%) | Sabse serious - immediate treatment zaroori |
| Raised IOP | Common (steroids mein zyada) | Usually transient |
| Vitreous hemorrhage | Uncommon | Retinal trauma se |
| Retinal detachment | Very rare | |
| RPE tear | 5-20% | Anti-VEGF + PED mein |
| Cataract | Steroids mein | Posterior subcapsular |
| Subconjunctival hemorrhage | Common | Benign, resolves spontaneously |
| Endophthalmitis (sterile) | Rare | Inflammatory, not infectious |
Key Clinical Points (Exam Important)
- Most common intravitreal procedure in the US and world - anti-VEGF injections
- Triamcinolone - pregnancy mein safe (diabetes maculopathy ke liye)
- Brolucizumab - longest duration among anti-VEGF but rarely causes severe inflammation
- DRCR.net Protocol T - aflibercept, bevacizumab, ranibizumab mein 5-year VA outcome same
- Vancomycin + Ceftazidime = empiric endophthalmitis treatment (cover both Gram+ and Gram-)
- Avastin (bevacizumab) = off-label but most widely used worldwide (cheapest)
Sources:
- Kanski's Clinical Ophthalmology 10th ed., pp. 345, 530
- Wills Eye Manual, 8th ed. - Procedure steps, drug protocols
- Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 1488 - Anti-VEGF drug table
- ASRS Patient Guide on Intravitreal Injections
- AAO Intravitreal Injection Guide
Glaucoma mebhuye damage nerves ko thik liya ja sakta hai kya
Reading File
Searching the Web
can glaucoma optic nerve damage be reversed or repaired 2024 2025
Finding Sources
Finding Sources
Searching PubMed
glaucoma optic nerve regeneration neuroprotection
Finding Sources
Searching PubMed
retinal ganglion cell neuroprotection glaucoma
Finding Sources
Reading File
Reading File
Ab mere paas poori information hai. Ek comprehensive aur clear answer deta hoon.
Glaucoma mein Damaged Nerves Thik Ho Sakti Hain Kya?
Direct Jawab: Nahi - Abhi Tak Possible Nahi Hai
Jo optic nerve damage glaucoma mein ho jaati hai, woh permanently irreversible hai. Yeh medical science ka ek confirmed fact hai. Jo vision chali gayi, woh wapas nahi aati.
"The goal of glaucoma treatment is to SLOW the rate of progression... in order to MAINTAIN visual function" - Kanski's Clinical Ophthalmology 10th ed.
Kyun Thik Nahi Hoti? - Biology Samjho
Retinal Ganglion Cells (RGC) Kya Hain?
- Optic nerve 1.2 million retinal ganglion cells ke axons se bani hoti hai
- Yeh cells retina se brain tak signal bhejti hain
- Glaucoma mein yeh cells apoptosis (programmed cell death) ke through marti hain
Death Kaise Hoti Hai?
Kanski's ke according, damage ka process:
- Mechanical injury - Raised IOP se nerve fibers lamina cribrosa par compress hoti hain
- Ischaemic injury - Blood vessels compress hone se optic nerve ko oxygen nahi milti
- Common pathway - Axoplasmic flow ruk jaata hai, growth factors nahi milte, oxidative damage hota hai, calcium influx hota hai cell mein, nitric oxide badhta hai
- Final result - RGC apoptosis se mar jaati hain
CNS Rule
Optic nerve Central Nervous System (CNS) ka part hai (brain + spinal cord + eye). CNS mein injured mature axons regrow nahi kar sakte - yeh peripheral nerves se alag hai. CNS ke environment mein regeneration inhibiting signals hote hain aur regeneration stimulating signals nahi hote. - Glaucoma Research Foundation
Toh Treatment Kya Karta Hai?
Treatment sirf aage ki damage rokti hai - nerve ko heal nahi karta.
Treatment Options:
| Category | Method | Kaam kya karta hai |
|---|---|---|
| Eye drops | Timolol, Latanoprost, Brimonidine, Dorzolamide | IOP (eye pressure) kam karta hai |
| Laser | SLT (Selective Laser Trabeculoplasty), YAG PI | Aqueous drainage badhata hai |
| Surgery | Trabeculectomy, Tube shunt | Permanent drainage channel banata hai |
Sab ka ek hi goal: IOP kam karo, nerve ki further damage roko.
Kitna Realistic Hai? - Progression Data
Early Manifest Glaucoma Trial (EMGT) ke according, bina treatment ke:
- High tension glaucoma: -1.31 dB/year visual field loss
- Normal tension glaucoma: -0.36 dB/year
- Pseudoexfoliation glaucoma: -3.13 dB/year
Average untreated patient normal vision se blindness tak ~25 saal mein jaata hai. Treatment yeh rate significantly slow kar deti hai - Kanski's, p. 364.
Future mein Kya Umeed Hai? (Research)
Yeh abhi sirf research stage mein hai, clinical practice mein nahi aaya:
1. Neuroprotection (Nerve Protection)
- RIP1 inhibitors jo RGC death ko rokein (Cell Death & Differ, 2025)
- Astrocyte reactivity ko modify karna (Nature, 2024 - PMID 38086421)
- Nitric oxide pathway ko target karna
2. Optic Nerve Regeneration
- Oncomodulin - Harvard research: naturally occurring growth promoter jo nerve regeneration trigger kare
- Protrudin molecule - Cambridge University research: scaffolding molecule jo nerve fibers ko retina-brain connection rebuild karne mein madad kare - CERA Research
3. Stem Cell Therapy
- UC Davis, 2025: Stem cells se optic nerve repair - early experiments mein promising results
Dr. Martin (Cambridge): "In the past it seemed impossible that we'd be able to regenerate the optic nerve. We can potentially do this now, but it remains to be seen how much vision can be restored."
Sabse Zaroori Baat - Patient ke Liye
GLAUCOMA = SILENT THIEF OF SIGHT
Jo damage ho gaya → PERMANENT hai
Jo damage nahi hua → PROTECT karo
Early detection + Regular treatment = Best outcome
- Glaucoma asymptomatic hai - symptoms tab aate hain jab bahut damage ho chuka hota hai
- Regular IOP checkup aur visual field test karte raho
- Diagnosis ke baad lifelong treatment chalu rakhni hoti hai - kabhi band mat karo doctor ke bina
- Family history hai toh 40 saal ki umar ke baad annual eye exam zaroor karwao
Sources: Kanski's Clinical Ophthalmology 10th ed., pp. 362-365 | Robbins & Cotran Pathologic Basis of Disease | Glaucoma Research Foundation | BrightFocus Foundation, Jan 2025 | PubMed: Jayaram et al., Lancet 2023 (PMID 37742700) | Bou Ghanem et al., Prog Retin Eye Res 2024 (PMID 38527623)
This is a shared conversation. Sign in to Orris to start your own chat.